Re using data collected from around 4,000 healthy people in the UK has enabled scientists to identify a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. The study, published today [16 September] , is the ... MyScience, 3 days ago
New recommendations about cholesterol were announced by the National Lipid Association (NLA) that focus on patient-centered ways to reduce and prevent cardiovascular events where patients and providers will work more collaboratively. The ...Pharmacist.com, 2 days ago
Pivotal anuncia un ensayo que muestra los efectos beneficiosos de VASCAZEN® para corregir la deficiencia de Omega-3
/PRNewswire/ -- - Pivotal anuncia la publicación de un ensayo clínico que muestra los efectos beneficiosos de VASCAZEN® en la corrección de la deficiencia de Omega-3 en pacientes cardiovasculares Pivotal Therapeutics Inc. (OTCQX:PVTTF; ...PR Newswire, 4 days ago Pivotal Publishes Results of Clinical Trial Showing Beneficial Effects of VASCAZEN in Correction of Omega-3 Deficiency In Cardiovascular Patients Individual.com, 4 days ago Pivotal's Vascazen improves omega-3 levels, says study Stockwatch, 1 week ago Pivotal Therapeutics Inc (PVTTF: OTCQX International) | Pivotal Announces Publication of a Clinical Trial Showing Beneficial Effects of VASCAZEN® In The Correction of Omega-3 Deficiency In Cardiovascular Patients Pink Sheets, 1 week ago
When we think of ways to prevent or treat cancer, temperature control usually isn't high on the list. But, researchers at the University of Wisconsin-Madison, led by Dr. Caroline Alexander at the McArdle Laboratory for Cancer Research, have made ...Individual.com, 1 week ago
Influence of Fenofibrate Treatment on Triacylglycerides, Diacylglycerides and Fatty Acids in Fructose Fed Rats
by Thomas Kopf, Hans-Ludwig Schaefer, Martin Troetzmueller, Harald Koefeler, Mark Broenstrup, Tatiana Konovalova, Gerd Schmitz Fenofibrate (FF) lowers plasma triglycerides via PPARα activation. Here, we analyzed lipidomic changes upon FF treatment ...Plosone.org, 1 week ago
New Biology Findings from Sichuan Agricultural University Outlined (Three Novel Single Nucleotide Polymorphisms of the 3-hydroxy-3-methylglutaryl...
New Biology Findings from Sichuan Agricultural University Outlined (Three Novel Single Nucleotide Polymorphisms of the 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Gene Associated with Egg-production in Chicken) By a News Reporter-Staff News ...4 Traders, 2 weeks ago
Mr. James is 58 years old, has a history of hypertension, and family history of premature coronary artery disease. He smokes half to one pack of cigarettes per day. His father, who was also a smoker, had a 2 vessel CABG at the age of 53 years. He is ...Consultant Live, 2 weeks ago Statins and New-onset Diabetes: Who is at Risk? Consultant Live, 2 weeks ago
Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol
Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction Amgen (NASDAQ: AMGN) today announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol ReductionUsing a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular ...Asian Hospital & Healthcare Management, 2 weeks ago Late-stage trial finds Amgen's cholesterol-lowering drug effective with statins MedCity News, 3 weeks ago Amgen's Cholesterol Lowering Drug Succeeds In Phase 3 Trial BioSpace, 3 weeks ago AMGEN : Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol 4 Traders, 3 weeks ago
By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C. , NewsRx journalists report that a patent application by the inventors Milne, Jill C. ( Brookline, MA ); Jirousek, Michael R. ( Cambridge, MA ); Bemis, Jean E. ( ...4 Traders, 3 weeks ago
Patent Application Titled "Polyunsaturated Fatty Acids for the Treatment of Diseases Related to Cardiovascular, Metabolic and Inflammatory Disease...
Patent Application Titled "Polyunsaturated Fatty Acids for the Treatment of Diseases Related to Cardiovascular, Metabolic and Inflammatory Disease Areas" Published Online By a News Reporter-Staff News Editor at Biotech Week -- According to news ...4 Traders, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!